CNSide Diagnostics will present data from the FORESEE trial showcasing the CNSide CSF Assay Platform’s utility in diagnosing and guiding ...
AstraZeneca’s Tagrisso (osimertinib) has been recommended for approval in the EU for treating adult patients with ...
The global pulmonology devices market is poised for unprecedented expansion, with key factors such as an aging population and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback